Histology and molecular profiling of small-bowel biopsies to improve celiac care
Official title: Histological and Molecular Profiling in the Diagnostics and Treatment of Small-Bowel Diseases - A Prospective Cohort Study (The DeepBowel Study)
Run by Tampere University Hospital · NCT07556328 · Data updated 2026-11-12
This project will test whether digital imaging, AI, gene-level profiling, and lab-grown intestinal cells can help diagnose and understand celiac disease and related small-bowel problems in adults having a gastroscopy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Tampere University Hospital Academic / other |
| Locations | 3 sites (Tampere and 2 other locations) |
| Status | Recruiting |
| Started | November 1, 2025 |
| Main results expected | December 31, 2035 |
| Study ends | December 31, 2035 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT07556328 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) scheduled for a clinically indicated gastroscopy, including those referred for primary celiac diagnostics, healthy controls with negative celiac antibodies, and patients with small‑bowel mucosal injury not responding to a gluten‑free diet, are the intended participants.
✕Probably not a fit
People who are under 18, unable to provide informed consent, have other small‑bowel diseases causing mucosal injury (for healthy control enrollment), or are not undergoing endoscopy are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective cohort collects duodenal biopsies from three adult groups: healthy controls undergoing clinically indicated gastroscopy with negative celiac antibodies, people referred for primary celiac diagnostics, and patients with persistent small-bowel mucosal injury despite a gluten‑free diet. Biopsies will be digitized for AI-based morphometry to establish reference villus-to-crypt ratios and reduce observer variability. Samples will also undergo RNA sequencing to profile molecular pathways and comparison with drug-trial datasets, and intestinal organoids will be grown to model disease progression and refractory injury. Research samples will be pseudonymized and processed at the Tampere University Celiac Disease Research Center, with statistical analyses performed in collaboration with the study statistician.
Why it matters
Potential benefit: If successful, the work could make biopsy readings more accurate and provide molecular markers to guide diagnosis and treatment decisions for celiac and refractory small-bowel disease.
How similar studies have gone: AI and digital morphometry have shown promise in improving histology reproducibility in related work, while combining transcriptomics and organoid modeling in celiac disease is relatively novel and less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Clinically indicated upper gastrointestinal endoscopy (gastroscopy) * Written informed consent obtained prior to procedure * For Group 1 (Healthy Controls): Negative celiac disease antibodies (anti-transglutaminase and/or anti-endomysium); no suspected celiac * For Group 2 (Celiac Diagnostics): Referred for primary celiac disease diagnostics requiring duodenal biopsy * For Group 3 (Refractory Injury): Confirmed small-bowel mucosal injury not responsive to a gluten-free diet Exclusion Criteria: * For Group 1 (Healthy Controls): Other small-bowel diseases causing mucosal injury, including Crohn's disease and small-bowel ulcers * Inability to provide written informed consent * Refusal to participate
Where it's running
-
Hatanpää Specialist Medical Care
Tampere, Finland Recruiting -
Tampere University Hospital (Tays)
Tampere, Finland Recruiting -
Valkeakoski Regional Hospital
Valkeakoski, Finland Recruiting
Study contacts
- Study coordinator: Juha Taavela
- Email: juha.taavela@tuni.fi
- Phone: +358443400330
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mediterranean diet and processed food in adults with celiac disease on a gluten-free diet
This observational study looks at whether following a Mediterranean-style diet or eating more highly processed foods affects GI symptoms and quality of life in adults with celiac disease who have been on a strict gluten-free diet.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity
This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.
-
Omega-3 fats to reduce inflammation in adults with newly diagnosed celiac disease
This study tests whether adding omega-3 fatty acid supplements to a gluten-free plan helps reduce inflammation and promote intestinal healing in adults who have just been diagnosed with celiac disease.
-
Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease
This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.